Diagnosis of mucopolysaccharidoses in a clinically selected population by urinary glycosaminoglycan analysis: a study of 2,000 urine samples.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  1993-11-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0009-8981(93)90031-XPMID 8149634
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pitfalls of screening for mucopolysaccharidoses by the dimethylmethylene blue test.

  1993cited by this paper
• Human Serum and Urine Glycosaminoglycans in Health and in Patients with Chronic Renal Failure

  1992cited by this paper
• Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue.

  1992cited by this paper
• Hunter disease (mucopolysaccharidosis type II) in a karyotypically normal girl

  1990cited by this paper
• Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses.

  1989cited by this paper
• Diagnostic test for mucopolysaccharidosis. I. Direct method for quantifying excessive urinary glycosaminoglycan excretion.

  1989cited by this paper
• Glycosaminoglycan excretion in connective tissue diseases.

  1988cited by this paper
• Urinary Glycosaminoglycans in Patients with Hypothyroidism and in Healthy Subjects

  1988cited by this paper
• Multiple sulfatase deficiency with a novel biochemical presentation

  1988cited by this paper
• Urinary excretion of glycosaminoglycans in urological disease.

  1987cited by this paper
• Screening for mucopolysaccharide disorders with the Berry spot test.

  1987cited by this paper
• β-Glucuronidase Deficiency: A Heterogeneous Mucopolysaccharidosis

  1985cited by this paper
• Beta-glucuronidase deficiency. A heterogeneous mucopolysaccharidosis.

  1985cited by this paper
• Urinary glycosaminoglycans in aspartylglycosaminuria: evidence for disturbed proteoglycan metabolism.

  1985cited by this paper
• Enzymatic determination of urinary glycosaminoglycans from orthopedic patients.

  1983cited by this paper
• Abnormal urinary excretion of glycosaminoglycans in Albers-Schönberg disease.

  1982cited by this paper
• Acid Mucopolysaccharide (AMPS) Abnormality in Multiple Sulfatase Deficiency: Chemical Compositions of AMPS in Urine and Liver

  1982cited by this paper
• [Mucopolysaccharidosis type VII. Clinical, radiological and biochemical studies in a neonatal case (author's transl)].

  1981cited by this paper
• Urinary glycosaminoglycan excretion as a biochemical marker in patients with bladder carcinoma.

  1981cited by this paper
• Urinary excretion of glycosaminoglycans and hydroxyproline in Paget's disease of bone, compared with neoplastic invasion of bone

  1981cited by this paper
• A review and selection of simple laboratory methods used for the study of glycosaminoglycan excretion and the diagnosis of the mucopolysaccharidoses.

  1976cited by this paper
• Oligosaccharides in urine of patients with glycoprotein storage diseases. I. Rapid detection by thin-layer chromatography.

  1975cited by this paper
• Identification and quantitation of keratan sulfate in urine.

  1974cited by this paper
• Eine mikromethode 7air kreatininbestimmung

  1971cited by this paper
• [Micro-determination of creatinine].

  1971cited by this paper
• A modified screening test for glycosaminoglycan excretion.

  1969cited by this paper
• Analytical and preparative separation of acidic glycosaminoglycans by electrophoresis in barium acetate.

  1968cited by this paper
• Diagnosis of Hurler's syndrome in the hospital laboratory and the determination of its genetic type.

  1966cited by this paper
• A new specific color reaction of hexuronic acids.

  1947cited by this paper

• Development and characterization of a model of mucopolysaccharidosis type IVA for evaluating therapies targeting bone disease.

  2026cites this paper
• Advances in glycosaminoglycan based diagnostic strategies for mucopolysaccharidoses

  2026cites this paper
• Mucopolysaccharidoses: A biochemical study under limited resources

  2025cites this paper
• Extracellular vesicles from microglial cells activated by abnormal heparan sulfate oligosaccharides from Sanfilippo patients impair neuronal dendritic arborization

  2024cites this paper
• Isolation, digital analysis, and semi-quantification of harmaline and harmine from Peganum harmala L.

  2024cites this paper
• Calculation of continuous reference intervals for biological parameters exhibiting strong age‐dependent level changes: Its application to glycosaminoglycans and sialic acid in urine

  2024cites this paper
• Identification of genetic variants associated with a wide spectrum of phenotypes clinically diagnosed as Sanfilippo and Morquio syndromes using whole genome sequencing

  2023cites this paper
• Evaluation of Patients Referred to Children's Medical Center Laboratory for Diagnosis of Mucopolysaccharidoses: Eight Years' Experience from Iran

  2021cites this paper
• Morquio B disease: From pathophysiology towards diagnosis.

  2021cites this paper
• [Mucopolysaccharidosis: A review].

  2020cites this paper
• Chondroitin sulfate disaccharide is a specific and sensitive biomarker for mucopolysaccharidosis type IVA

  2020cites this paper
• Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management

  2020cites this paper
• Mucopolysaccharidosis VI diagnosis by laboratory methods

  2018cites this paper
• Differential diagnosis of mucopolysaccharidosis and oligosaccharidosis of a sample of Egyptian children

  2018cites this paper
• Les mucopolysaccharidoses vues chez l’adulte en rhumatologie

  2018cites this paper
• Contribution of tandem mass spectrometry to the diagnosis of lysosomal storage disorders

  2018cites this paper
• Predominant role of microglia in brain iron retention in Sanfilippo syndrome, a pediatric neurodegenerative disease

  2018cites this paper
• Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.

  2018cites this paper
• Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis.

  2018cites this paper
• Clinical presentation and diagnosis of mucopolysaccharidoses.

  2018cites this paper
• Haematopoietic stem cell transplantation for mucopolysaccharidosis type VII: A case report

  2018cites this paper
• Recent advances in molecular testing to improve early diagnosis in children with mucopolysaccharidoses

  2018influential citation
• International working group identifies need for newborn screening for mucopolysaccharidosis type I but states that existing hurdles must be overcome

  2018cites this paper
• Mis-splicing of the GALNS gene resulting from deep intronic mutations as a cause of Morquio a disease

  2018cites this paper
• Mucopolysaccharidosis IVA and glycosaminoglycans.

  2017cites this paper
• Lysosomal storage disorders: Sphingolipidoses

  2017cites this paper
• Mucopolysaccharidoses seen in adults in rheumatology.

  2017cites this paper
• Measurement of Elevated Concentrations of Urine Keratan Sulfate by UPLC-MSMS in Lysosomal Storage Disorders (LSDs): Comparison of Urine Keratan Sulfate Levels in MPS IVA Versus Other LSDs.

  2016influential citation
• Total and single species of uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3days of age for early diagnosis application.

  2016cites this paper
• Use of a commercial agarose gel for analysis of urinary glycosaminoglycans in mucopolysaccharidoses

  2016cites this paper
• Enzyme Replacement Therapy in Lysosomal Storage Diseases

  2015cites this paper
• Serum dipeptidyl peptidase-IV: a better screening test for early detection of mucopolysaccharidosis?

  2014cites this paper
• Assessment of respiratory involvement in children with mucoplysaccharidosis using pulmonary function tests

  2014cites this paper
• [Current therapeutic strategies in lysosomal disorders].

  2014cites this paper
• Análises bioquímicas em amostras de urina e sangue colhidas em papel filtro : uma alternativa para triagem de mucopolissacaridoses I e VI

  2014cites this paper
• Molecular characteristics of patients with glycosaminoglycan storage disorders in Russia.

  2014cites this paper
• The laboratory diagnosis of mucopolysaccharidosis III (Sanfilippo syndrome): A changing landscape.

  2014cites this paper
• Diagnosing mucopolysaccharidosis IVA

  2013influential citation
• The Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects.

  2013cites this paper
• 39 Lysosomal Storage Diseases

  2012cites this paper
• Mucopolysacccharidoses: From understanding to treatment, a century of discoveries

  2012cites this paper
• Diagnosing Hunter syndrome in pediatric practice: practical considerations and common pitfalls

  2012cites this paper
• Expert recommendations for the laboratory diagnosis of MPS VI.

  2012cites this paper
• Cascades physiopathologiques dans la maladie de Sanfilippo B

  2012cites this paper
• Lysosomal storage diseases

  2012cites this paper
• Therapy for the mucopolysaccharidoses.

  2011cites this paper
• Lysosomal storage diseases: Diagnostic confirmation and management of presymptomatic individuals

  2011cites this paper
• Diagnosis of the mucopolysaccharidoses.

  2011cites this paper
• La maladie de Hurler : à propos de 30 cas

  2011cites this paper
• Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis

  2009cites this paper
• Neurodevelopmental disorders; yield of extended investigations

  2009cites this paper
• Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years.

  2009cites this paper
• Early Neurodegeneration Progresses Independently of Microglial Activation by Heparan Sulfate in the Brain of Mucopolysaccharidosis IIIB Mice

  2008cites this paper
• Yield of additional metabolic studies in neurodevelopmental disorders

  2008cites this paper
• [Diagnostic strategy of mucopolysaccharidosis type I in Tunisia].

  2007cites this paper
• Comparative studies on the analysis of urinary trypsin inhibitor (ulinastatin) preparations

  2006cites this paper
• Second‐trimester diagnosis of mucopolysaccharidosis type IV a presenting as hydrops fetalis

  2006cites this paper
• Prenatal diagnosis of congenital chylothorax associated with de novopartial trisomy 12q (12q21.2→qter)

  2006cites this paper
• Lysosomal storage disorders.

  2006cites this paper
• Diagnosis of mucopolysaccharidoses: How to avoid false positives and false negatives

  2004cites this paper
• Evaluation of reliability for urine mucopolysaccharidosis screening by dimethylmethylene blue and Berry spot tests.

  2004cites this paper
• Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources

  2003cites this paper
• Mucopolysaccharidose de type I au Maroc: manifestations cliniques et profil génétique

  2000cites this paper
• [Mucopolysaccharidosis type I in Morocco: clinical features and genetic profile].

  2000cites this paper
• Bladder obstruction in Hunter's syndrome.

  1999cites this paper
• Diagnostic biologique et moléculaire des maladies de surcharge lysosomale

  1998cites this paper
• Follow-up of nine patients with Hurler syndrome after bone marrow transplantation.

  1998cites this paper
• Mucopolysaccharidoses

  1996cites this paper
• Amniotic fluid for screening of lysosomal storage diseases presenting in utero (mainly as non-immune hydrops fetalis).

  1996cites this paper